Clinical Trial Update: Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tri-weekly TJ to weekly TJ in stage II-IV Mullerian carcinoma (epithelial ovarian cancer and related cancers) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• TJ

Snippet

Sponsor: Japanese Gynecologic Oncology Group | Conditions: Epithelial Ovarian Cancer, Primary Peritoneal Cancer | Phase 3 | Status: COMPLETED